Pathway Eased for Serial COVID-19 Screening Tests | Regulatory Agencies | JN Learning | AMA Ed Hub [Skip to Content]
[Skip to Content Landing]

Pathway Eased for Serial COVID-19 Screening Tests

Educational Objective
To identify the key insights or developments described in this article
1 Credit CME

The FDA has created an expedited pathway for manufacturers seeking to obtain Emergency Use Authorization for products used in serial testing to detect SARS-CoV-2 in asymptomatic individuals. Currently, most tests are authorized for diagnosing people with a suspected infection.

Serial testing involves testing the same person more than once over a few days to increase the chances of detecting asymptomatic infection that a single test might not detect. The simplified recommendations apply to molecular and antigen tests used serially in any location, from point-of-care settings to homes, schools, airports, or sports venues.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

The FDA has created an expedited pathway for manufacturers seeking to obtain Emergency Use Authorization for products used in serial testing to detect SARS-CoV-2 in asymptomatic individuals. Currently, most tests are authorized for diagnosing people with a suspected infection.

Serial testing involves testing the same person more than once over a few days to increase the chances of detecting asymptomatic infection that a single test might not detect. The simplified recommendations apply to molecular and antigen tests used serially in any location, from point-of-care settings to homes, schools, airports, or sports venues.

A supplement to existing policy allows manufacturers whose tests for symptomatic individuals have achieved a positive percent agreement of at least 80% to request authorization for serial testing in asymptomatic people before they have validation data for that group.

If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
Close
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close